Both carvacrol and metformin treatments significantly promoted the phosphorylation of PI3K, PDK1, and AKT and significantly reduced the expression of PTEN phosphorylation in mice with T2DM compared with vehicle treatment (P < 0.05). This evidence concerns the gene AKT1 and type 2 diabetes mellitus.